Skip to main content
Focused investors/Seth Klarman

Seth Klarman - Baupost Group

As of Q2 2026, Seth Klarman reported 23 long-equity positions worth $5.42B in aggregate.

Copy-investor backtest

Latest quarter
+3.22%
1-year
+20.94%
3-year
+48.31%
5-year
+12.01%
3-year vs S&P 500
-25.70%
5-year vs S&P 500
-61.90%
5-year top 5
-0.29%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when Seth Klarman files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 10 of 39 rows. Rows without a quote are marked unavailable.

1SYFSYNCHRONY FINL11.22%-29,295,030$1.13B$38.61No quote
2LNGCHENIERE ENERGY INC11.07%-20,726,340$1.12BNo quoteNo quote
3VSATVIASAT INC9.77%-13,158,137$984.89M$74.85No quote
4FOXATWENTY FIRST CENTY FOX INC7.63%Add +16.5%22,288,731$769.63M$34.53No quote
5TWXTIME WARNER INC7.35%New8,100,000$740.91MNo quoteNo quote
6AGNALLERGAN PLC7.30%Add +51.8%4,500,000$736.11MNo quoteNo quote
7QRVOQORVO INC7.27%Add +22.2%11,000,000$732.6M$66.60No quote
8CLNSCOLONY NORTHSTAR INC5.42%-47,905,461$546.6MNo quoteNo quote
9ARANTERO RES CORP4.66%Add +3.4%24,722,187$469.72M$19.00No quote
10PBFPBF ENERGY INC3.84%Reduce -30.5%10,924,175$387.26M$35.45No quote
11FOXTWENTY FIRST CENTY FOX INC3.56%Add +42.6%10,531,258$359.33M$34.12No quote
12PXDPIONEER NAT RES CO3.43%Add +6821.6%2,000,000$345.7MNo quoteNo quote
13CAHCARDINAL HEALTH INC3.10%Add +101.6%5,100,000$312.48M$61.27No quote
14TBPHTHERAVANCE BIOPHARMA INC2.58%-9,309,168$259.63MNo quoteNo quote
15MCKMCKESSON CORP2.10%Add +172.0%1,360,000$212.09M$155.95No quote
16ESRXEXPRESS SCRIPTS HLDG CO1.71%Reduce -9.8%2,306,456$172.15MNo quoteNo quote
17CORAMERISOURCEBERGEN CORP1.31%Add +659.6%1,434,565$131.72MNo quoteNo quote
18KERXKERYX BIOPHARMACEUTICALS INC1.19%-25,791,678$119.93MNo quoteNo quote
19VRTVVERITIV CORP1.04%Add +19.3%3,641,485$105.24MNo quoteNo quote
20ATRAATARA BIOTHERAPEUTICS INC0.96%-5,359,632$97.01MNo quoteNo quote
21AMCAMC ENTMT HLDGS INC0.75%Add +40.2%5,000,000$75.5MNo quoteNo quote
22GTYHUGTY TECHNOLOGY HOLDINGS INC0.45%-4,400,000$45.38MNo quoteNo quote
23PRTKPARATEK PHARMACEUTICALS INC0.43%-2,394,498$42.86MNo quoteNo quote
24NGNOVAGOLD RES INC0.42%Add +13.1%10,742,835$42.22M$3.93No quote
25CASCCASCADIAN THERAPEUTICS INC0.32%-8,721,079$32.27MNo quoteNo quote
26IMOSCHIPMOS TECHNOLOGIES INC0.26%Reduce -51.8%1,470,408$25.95MNo quoteNo quote
27SCACSABAN CAP ACQUISITION CORP0.23%-2,326,500$23.1MNo quoteNo quote
28RUNSUNRUN INC0.17%-2,848,082$16.8MNo quoteNo quote
29STNLUSENTINEL ENERGY SVCS INC0.16%New1,600,000$15.95MNo quoteNo quote
30FWPFORWARD PHARMA A/S0.15%Reduce -35.3%4,179,940$15.38MNo quoteNo quote
31TMQTRILOGY METALS INC NEW0.11%-10,600,758$11.5MNo quoteNo quote
32OREXOREXIGEN THERAPEUTICS INC0.03%-2,226,839$2.87MNo quoteNo quote
33SCACWSABAN CAP ACQUISITION CORP0.01%-1,163,250$1.44MNo quoteNo quote
38SMPLWSIMPLY GOOD FOODS CO-Sold0$0No quoteNo quote
37SRUNSILVER RUN ACQUISITION-Sold0$0No quoteNo quote
36DVMTDELL TECHNOLOGIES INC-Sold0$0No quoteNo quote
35CDEVCENTENNIAL RESOURCE DEV INC-Sold0$0No quoteNo quote
34CARAVIS BUDGET GROUP-Sold0$0No quoteNo quote

Other instruments

Bonds, warrants, or non-share principal positions reported alongside the equity portfolio.

1TBPH 3.25 11/01/23THERAVANCE BIOPHARMA INCNOTE 3.250%11/0OTHER30,000,000$33.04M